January is Cervical Cancer Awareness Month. Each year, more than 3,200 women are diagnosed with cervical cancer in the UK. This type of cancer can affect people of all ages. Here you will find more ...

World Cancer Day is on 4 February 2026. We're raising awareness of just how many people around the UK have their lives changed by a cancer diagnosis. We're also sharing ways to get support, and how ...

We have developed a best practice resource for clinicians and healthcare professionals involved in any aspect of cancer care in the last years of life. This resource includes: case studies and ...

Find out more about cancer, from A to Z. Get information and support about diagnosis, treatment, side effects and follow-up, as well as your feelings, money and work.

Ready to take on your charity hike? Choose Mighty Hikes. Whether you want to stroll across the Thames or the Lake District. We have a charity event for you.

Squamous cell cancer starts in cells that line different parts of the body, such as the airways. It is the most common type of tracheal cancer. It is more common in people over 60 and usually affects ...

Starting in Callander, the Rob Roy Mighty Hike is your chance to tread the Great Trossachs Park, leading you above Loch Venachar and then onto Loch Drunkie. Prepare for some long, slow climbs that ...

Choose from 12 stunning locations across UK and join 35,000 fellow hikers to raise life-changing funds for people living with cancer.

Bisphosphonates are drugs that help to protect the bones against some effects of breast cancer treatment. They can also help reduce the risk of breast cancer coming back after treatment. help protect ...

Cetuximab is also called Erbitux ®. It is a type of targeted therapy drug called a monoclonal antibody. Cetuximab is used to treat bowel (colon and rectal) cancer and head and neck cancer. It may ...

If you are transgender (trans), non-binary, or both, you may have questions about how this may affect your risk of cancer, or the screening or treatment you may need. Your gender identity should not ...